関連する実験動画
Updated: Jan 9, 2026
01:27
Pulmonary Embolism III: Nursing Management
Published on: June 19, 2025
320
哺乳類の変異は,高度に移動性の高いソマティック・スリーピング・ビューティのトランポソン系を用いて行われます
Adam J Dupuy1, Keiko Akagi, David A Largaespada
1National Cancer Institute, Center for Cancer Research, Frederick, Maryland 21702, USA.
Nature
|July 15, 2005
まとめ
スリーピング・ビューティ (SB) のトランスポゾン技術は,マウスの高周波遺伝子操作を可能にし,がんを誘発し,複雑な疾患の遺伝子発見を促進します. この強力なツールは,より高いユカリオットの遺伝子スクリーンを前進させるのに役立ちます.
科学分野:
- 遺伝学 遺伝学とは
- 分子生物学は分子生物学である.
- がん研究 がん研究
背景:
- トランポゾンは,下層のエウカリオートにおける機能的なゲノムスクリーンのための貴重な遺伝的ツールです.
- 高級エウカリオットにおけるそれらの有用性は,低転移周波数によって制限されています.
研究 の 目的:
- スリーピング・ビューティ (SB) のトランポゾンの有効性を,より高い真核生物で実証するために.
- マウスの体細胞における高周波挿入型変異生成のためのツールとしてSBを確立する.
主な方法:
- マウスの体細胞における眠れる美人 (SB) トランスポゾン (SB) の動員.
- 癌の遺伝子機能を研究するために挿入性変異遺伝子の誘導.
- 腫瘍の発達と遺伝子変化の分析.
主要な成果:
- SBの転移は,野生型のマウスの胚死亡率と癌を引き起こすのに十分な頻度で発生しました.
- 誘発された腫瘍は攻撃的であり,いくつかのマウスは複数の癌のタイプを発症しました.
- SB挿入性ミュータゲネシスは,がんの遺伝子と疾患誘導に不可欠な経路を特定しました.
結論:
- スリーピング・ビューティ (Sleeping Beauty, SB) のトランスポゾンは,哺乳類の体細胞における挿入性突然変異のための非常に効果的なツールです.
- SBは,がん遺伝子の機能の研究と,疾患を引き起こす経路の識別を容易にする.
- SB技術は,ヒトの疾患研究における応用を含む,様々な高級エウカリオットの先行遺伝子スクリーンの可能性を秘めています.
関連する概念動画
Pulmonary Embolism III: Nursing Management
320
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
320
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
277
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
277
Pulmonary Embolism I: Introduction
464
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
464
Venous Thrombosis III: Interprofessional Care
262
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
262
Pneumothorax-II
852
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
852
Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K